154 related articles for article (PubMed ID: 15493297)
41. Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands.
Byrtus H; Pawłowski M; Duszyńska B; Wesołowska A; Chojnacka-Wójcik E; Bojarski AJ
Pol J Pharmacol; 2001; 53(4):395-401. PubMed ID: 11990087
[TBL] [Abstract][Full Text] [Related]
42. Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
Ślifirski G; Król M; Kleps J; Ulenberg S; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Bojarski A; Kozioł AE; Turło J; Herold F
Eur J Med Chem; 2019 Mar; 166():144-158. PubMed ID: 30703658
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
Ślifirski G; Król M; Kleps J; Podsadni P; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Bojarski A; Kozioł AE; Turło J; Herold F
Eur J Med Chem; 2019 Oct; 180():383-397. PubMed ID: 31325785
[TBL] [Abstract][Full Text] [Related]
44. 7-3-Chlorophenypiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione as a serotonin receptor ligands with potential antidepressant activity.
Zygmunt M; Sapa J; Chłoń-Rzepa G; Zagórska A; Siwek A; Pawłowski M; Nowak G
Pharmacol Rep; 2014 Jun; 66(3):505-10. PubMed ID: 24905531
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus.
Fiorino F; Severino B; De Angelis F; Perissutti E; Frecentese F; Massarelli P; Bruni G; Collavoli E; Santagada V; Caliendo G
Arch Pharm (Weinheim); 2008 Jan; 341(1):20-7. PubMed ID: 18072244
[TBL] [Abstract][Full Text] [Related]
47. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
48. New piperidinyl- and 1,2,3,6-tetrahydropyridinyl-pyrimidine derivatives as selective 5-HT1A receptor agonists with highly potent anti-ischemic effects.
Kamei K; Maeda N; Katsuragi-Ogino R; Koyama M; Nakajima M; Tatsuoka T; Ohno T; Inoue T
Bioorg Med Chem Lett; 2005 Jun; 15(12):2990-3. PubMed ID: 15914001
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and 5-HT1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f]theophyllines.
Kołaczkowski M; Zajdel P; Fhid O; Duszyńska B; Tatarczyńska E; Pawłowski M
Pharmacol Rep; 2005; 57(2):229-35. PubMed ID: 15886422
[TBL] [Abstract][Full Text] [Related]
50. New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT
Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Kurczab R; Romeo G
Bioorg Med Chem; 2017 Feb; 25(3):1250-1259. PubMed ID: 28063784
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2,4-dione derivatives as ligands for the α1-adrenoceptors.
Pittalà V; Siracusa MA; Modica MN; Salerno L; Pedretti A; Vistoli G; Cagnotto A; Mennini T; Romeo G
Bioorg Med Chem; 2011 Sep; 19(17):5260-76. PubMed ID: 21802308
[TBL] [Abstract][Full Text] [Related]
52. Solid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one.
Grychowska K; Masurier N; Verdié P; Satała G; Bojarski AJ; Martinez J; Pawłowski M; Subra G; Zajdel P
Chem Biol Drug Des; 2015 Oct; 86(4):697-703. PubMed ID: 25684690
[TBL] [Abstract][Full Text] [Related]
53. Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity.
Bojarski AJ; Paluchowska MH; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Bioorg Med Chem; 2006 Mar; 14(5):1391-402. PubMed ID: 16266808
[TBL] [Abstract][Full Text] [Related]
54. A study on application of impregnated synthetic peptide TLC stationary phases for the screening of 5-HT1A ligands. Part 2.
Zajdel P; Bojarski AJ; Bugno R; Jurczyk S; Kołaczkowski M; Nowak M; Subra G; Martinez J; Pawłowski M
Biomed Chromatogr; 2004 Oct; 18(8):542-9. PubMed ID: 15386518
[TBL] [Abstract][Full Text] [Related]
55. Structure-5-HT/D
Żmudzki P; Satała G; Chłoń-Rzepa G; Bojarski AJ; Kazek G; Siwek A; Gryboś A; Głuch-Lutwin M; Wesołowska A; Pawłowski M
Arch Pharm (Weinheim); 2016 Oct; 349(10):774-784. PubMed ID: 27510801
[TBL] [Abstract][Full Text] [Related]
56. Thermogenesis in brown adipose tissue: increase by 5-HT2A receptor activation and decrease by 5-HT1A receptor activation in conscious rats.
Ootsuka Y; Blessing WW
Neurosci Lett; 2006 Mar; 395(2):170-4. PubMed ID: 16293365
[TBL] [Abstract][Full Text] [Related]
57. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity, part 1.
Herold F; Chodkowski A; Izbicki Ł; Król M; Kleps J; Turło J; Nowak G; Stachowicz K; Dybała M; Siwek A
Eur J Med Chem; 2009 Apr; 44(4):1710-7. PubMed ID: 18995929
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of new derivatives of 1-alkyl-2-aryl-1H-2,3-dihydroimidazo[1,2-a]pyrimidin-5-one active in CNS. Part 2. Synthesis and results of preliminary pharmacological screening of 7-(substituted)amino-1-alkyl-2-aryl-1H-2,3-dihydroimidazo[1,2-a]pyrimid in-5- ones.
Matosiuk D; Tkaczyński T; Stefańczyk J
Acta Pol Pharm; 1999; 56(3):215-9. PubMed ID: 10635361
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and pharmacological evaluation of new arylpiperazines N-[4-[4-(aryl) piperazine-1-yl]-phenyl]-amine derivatives: putative role of 5-HT1A receptors.
Khatri M; Rai SK; Alam S; Vij A; Tiwari M
Bioorg Med Chem; 2009 Mar; 17(5):1890-7. PubMed ID: 19223188
[TBL] [Abstract][Full Text] [Related]
60. Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
Butini S; Gemma S; Campiani G; Franceschini S; Trotta F; Borriello M; Ceres N; Ros S; Coccone SS; Bernetti M; De Angelis M; Brindisi M; Nacci V; Fiorini I; Novellino E; Cagnotto A; Mennini T; Sandager-Nielsen K; Andreasen JT; Scheel-Kruger J; Mikkelsen JD; Fattorusso C
J Med Chem; 2009 Jan; 52(1):151-69. PubMed ID: 19072656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
